A decade of advances in multiple myeloma and unanswered questions
Lenalidomide maintenance – an active approach to treating MM?
Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich
Challenges associated with long-term therapies in CLL
Mantle cell lymphoma highlights from ASH 2016: Lysa, PHILEMON results and more